References

Clinical Applications of Genomics : References

Lesson 6

The following page includes a quiz that will be used to assess your mastery of the lesson content. If you are completing the course for continuing education credit, you must successfully complete each lesson quiz. Go to Lesson 6 quiz.

1. U.S. Department of Energy. Office of Science. Human Genome Project Information Web site. Retrieved March 22, 2006, from http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml.
2. Walpole, I.R., Dawkins, H.J., Sinden, P.D., & O'Leary, P.C. (2003). Human gene patents: the possible impacts on genetic services healthcare. Medical Journal of Australia, 179, 203-205. PubMed
3. National Institutes of Health, National Library of Medicine. Online Mendelian Inheritance in Man (OMIM). Phenmylketonuria. Retrieved March 22, 2006 from http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=261600.
4. National Institutes of Health, National Library of Medicine. Online Mendelian Inheritance in Man (OMIM). Cystic Fibrosis. Retrieved March 22, 2006, from http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=219700.
5. Imperiale, T.F., Ransohoff, D.F., Itzkowitz, S.H., Turnbull, B.A., & Ross, M.E. (2004). Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. New England Journal of Medicine, 351, 2704-2724. PubMed
6. Conrads, T.P., Hood, B.L., Issaq, H.J., & Veenstra, T.D. (2004). Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Molecular Diagnosis, 8, 77-85. PubMed
7. Johnson, J.A. & Evans, W.E. (2002). Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity. Trends in Molecular Medicine, 8, 300-305. PubMed
8. Ibid.
9. Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hortnagel, K., Pelz, H.J., et al. (2004). Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature, 427, 537-541. PubMed
10. Antony, A.C., Kane, M.A., Portillo, R.M., Elwood, P.C., & Kolhouse, J.F. (1985). Studies of the role of a particulate folate-binding protein in the uptake of 5-methytetrahydrofolate by cultured human KB cells. Journal of Biological Chemistry, 260, 14911-14917. PubMed
11. Gottesman, M.M. & Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385-427. PubMed
12. Khoury, M.J., McCabe, L.L. & McCabe, E.R. (2003). Population screening in the age of genomic medicine. New England Journal of Medicine, 348, 50-58. PubMed
13. Druker B.J., O'Brien S.G., Cortes, J., & Radich J. (2002). Chronic myelogenous leukemia. Hematology (Am Soc Hematol Educ Program), 111-135. PubMed
14. Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M. et al. (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. New England Journal of Medicine. 351, 2817-2826. PubMed
15. Ellis, M. (2004). Overcoming endocrine therapy resistance by signal transduction inhibition. Oncologist, 9 (suppl 3), 20-26. PubMed
16. Kwiatkowska, E., Teresiak, M., Filas, V., Breborowicz, D., Mackiewicz, A., & Karczewska, A. (2003). BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clinical Cancer Research, 9, 4452-4459. PubMed
17. Hohlfeld, J., de Buys Roessingh, A., Hirt-Burri, N., Chaubert, P., Gerber, S., Scaletta, C. et al. (2005). Tissue engineered fetal skin constructs for paediatric burns. Lancet, 366, 840-842. PubMed
18. Agency for Healthcare Research and Quality. Preventive Services Web site. Retrieved March 22, 2006 from www.preventiveservices.ahrq.gov.
19. Centers for Disease Control and Prevention. Genomics and Disease Prevention Web site. Retrieved March 22, 2006, from http://www.cdc.gov/genomics/gtesting/egapp.htm.